Industries > Pharma > Global Biosimilars and Follow-On Biologics Market 2018-2028

Global Biosimilars and Follow-On Biologics Market 2018-2028

Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones

PUBLISHED: 01 June 2018
PAGES: 335
PRODUCT CODE: PHA0315

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global biosimilars and follow-on biologics market is estimated to have reached $7.70bn in 2017 and expected to grow at a CAGR of 23.8% in the first half of the forecast period. The market is dominated by Biosimilar Monoclonal Antibodies, this submarket is estimated to hold 24% share of this market by 2022.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 335-page report you will receive 131 tables and 68 figures– all unavailable elsewhere.

The 335-page report provides clear detailed insight into the global biosimilars and follow-on biologics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Biosimilars and Follow-on Biologics Market forecasts from 2018-2028

• Along with revenue prediction for the overall world market for biosimilars, our investigation shows forecasts to 2028 for 8 individual therapeutic submarkets:
• Monoclonal antibodies (mAbs)
• Fusion proteins
• Insulin
• Erythropoietin (EPO)
• Granulocyte colony-stimulating factor (G-CSF)
• Interferons
• Growth hormones
• Fertility hormones

• This report also shows revenue to 2028 for 12 individual submarkets within the above segments:
• Rituximab, infliximab, trastuzumab, adalimumab and bevacizumab
• Human insulin, insulin analogues, insulin glargine and insulin lispro
• Interferon alfa and interferon beta
• Etanercept

• Our analyses show individual revenue forecasts to 2028 for 12 national markets:
• US
• Japan
• Germany, France, UK, Italy and Spain
• China, India, South Korea, Russia and Brazil

Global Biosimilars and Follow-On Biologics Market 2018-2028

• Our study provides a SWOT analysis of the biosimilars and follow-on biologics market.

• Our study discusses pressures, opportunities and other events affecting the biosimilars industry and market, including these influences:
• Strategies for developing biosimilars – needs, demand, challenges and opportunities
• Guidelines from regulators (FDA, EMA and others)
• Patent challenges and data exclusivity for biopharmaceuticals
• Needs and opportunities in developing biosimilar mAbs, including rising incidence of cancers and increasing demand for lower-cost biologicals
• Developments in technology and operations for biosimilar drug production.

Visiongain’s study is intended for anyone requiring commercial analyses for the biosimilars and follow-on biologics market. You find data, trends and predictions.

Buy our report today Global Biosimilars and Follow-On Biologics Market 2018-2028: Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Biosimilars and Follow-On Biologics Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Biosimilars and Follow-On Biologics Market 2018-2028


Latest Pharma news

“Pharmaceutical Contract Manufacturing market set to grow to $138bn by 2024” says Visiongain report

In recent years, one area of biopharmaceutical manufacturing that has come under increasing interest is ADC manufacturing.

16 January 2020

READ

New Advances in the Wound Care Market

In recent years, with the advent of technology, medical practitioners and manufacturers have made huge strides in the wound care market. As one of today’s leading market research and report firms, Visiongain is committed to providing you the most up-to-date information about this exciting industry. That’s why below we’ve collected some of today’s latest products and technologies for your perusal.  …

14 January 2020

READ

Recent Highs & Lows in the Vaccine Market 

With the emergence of new health technology and advances in vaccines, manufacturers and key stakeholders can position themselves to generate big returns in the coming years. However, getting ahead of the competition will require having the right tools at your disposal, which is why Visiongain is proud to offer extensive vaccine market forecasts, as well as reports from other verticals …

14 January 2020

READ

Current Developments in the Global Dermatology Market Pipeline

New trials from around the world are affecting the global dermatology market on an almost daily basis, providing patients with new drugs and medical practitioners with more innovative treatment technology than ever before. That’s why Visiongain has made it their business to help inform key stakeholders and business owners about the most current changes and emerging trends.  Here are a …

14 January 2020

READ

Categories

Category